NEPH RSI Chart
Last 7 days
13.3%
Last 30 days
19.6%
Last 90 days
-32.2%
Trailing 12 Months
88.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 11.5M | 0 | 0 | 14.2M |
2022 | 9.7M | 10.3M | 10.2M | 10.0M |
2021 | 8.8M | 9.5M | 9.9M | 10.3M |
2020 | 0 | 0 | 0 | 8.6M |
2018 | 0 | 0 | 0 | 0 |
2017 | 2.5M | 2.8M | 3.3M | 0 |
2016 | 2.0M | 1.9M | 2.1M | 2.3M |
2015 | 1.8M | 1.9M | 1.8M | 1.9M |
2014 | 1.7M | 1.6M | 1.6M | 1.7M |
2013 | 1.8M | 2.1M | 1.9M | 1.7M |
2012 | 2.1M | 1.7M | 1.9M | 1.8M |
2011 | 2.6M | 2.5M | 2.2M | 2.2M |
2010 | 0 | 2.8M | 2.8M | 2.9M |
2009 | 0 | 0 | 0 | 2.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 13, 2024 | wexford capital lp | sold | - | - | -91,463 | - |
Mar 13, 2024 | amron arthur h | acquired | - | - | 91,463 | - |
Mar 12, 2024 | amron arthur h | bought | 17,129 | 2.4471 | 7,000 | - |
Dec 13, 2023 | amron arthur h | acquired | - | - | 9,291 | - |
Dec 13, 2023 | spandow oliver j. | acquired | - | - | 14,294 | - |
Dec 13, 2023 | lask alisa | acquired | - | - | 9,291 | - |
Dec 13, 2023 | harris joseph michael | acquired | - | - | 9,291 | - |
Dec 07, 2023 | banks robert r. jr. | bought | 39,646 | 2.2026 | 18,000 | president and ceo |
Aug 15, 2023 | banks robert r. jr. | bought | 3,206 | 1.6869 | 1,901 | president and ceo |
Aug 14, 2023 | banks robert r. jr. | bought | 148 | 1.5 | 99.00 | president and ceo |
Which funds bought or sold NEPH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | ELKHORN PARTNERS LIMITED PARTNERSHIP | added | 12.85 | -31,000 | 79,000 | 0.06% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -19,779 | 34,379 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -83.94 | -104,982 | 11,876 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -28.00 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 76.46 | 1,009 | 9,638 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 25,441 | 25,441 | -% |
May 15, 2024 | WEXFORD CAPITAL LP | reduced | -2.23 | -4,796,720 | 7,945,510 | 1.62% |
May 14, 2024 | NewEdge Advisors, LLC | new | - | 78.00 | 78.00 | -% |
May 13, 2024 | BARD ASSOCIATES INC | reduced | -4.24 | -255,287 | 392,834 | 0.14% |
May 13, 2024 | UBS Group AG | added | 2,690 | 634 | 672 | -% |
Unveiling Nephros Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Nephros Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Nephros Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 |
Revenue | -2.4% | 3,522,000 | 3,609,500 | 3,697,000 | 2,526,500 | 2,409,000 | 2,884,000 | 2,187,000 | 2,675,000 | 2,578,000 | 2,266,000 | 2,736,000 | 2,334,000 | 2,121,000 | 1,577,000 | 2,529,000 | 1,265,000 | 1,000 | 1,000 | 306,000 | 611,000 | 916,000 |
Gross Profit | 8.2% | 2,187,000 | 2,021,000 | 2,111,000 | 1,515,000 | 762,000 | 1,395,000 | 1,053,000 | 1,441,000 | 1,360,000 | 1,275,000 | 1,587,000 | 1,302,000 | 1,225,000 | 895,000 | 1,491,000 | 954,000 | 952,000 | 830,000 | - | - | - |
Operating Expenses | -10.6% | 2,387,000 | 2,670,000 | 2,417,000 | 2,208,000 | 2,043,000 | 2,209,000 | 2,600,000 | 1,959,000 | 2,162,000 | 2,392,000 | 2,605,000 | 2,021,000 | 2,157,000 | 2,493,000 | 2,517,000 | 1,683,000 | 1,463,000 | 1,483,000 | - | - | - |
S&GA Expenses | -11.2% | 2,142,000 | 2,411,000 | 2,124,000 | 1,787,500 | 1,743,000 | 1,885,000 | 2,177,000 | 1,723,000 | 1,718,000 | 1,854,000 | 1,999,000 | 1,362,000 | 1,544,000 | 1,610,000 | 1,950,000 | 1,097,000 | 1,069,000 | 1,091,000 | - | - | - |
R&D Expenses | 1.9% | 212,000 | 208,000 | 239,000 | 358,500 | 252,000 | 273,000 | 372,000 | 194,000 | 395,000 | 487,000 | 556,000 | 609,000 | 751,000 | 836,000 | 563,000 | - | 352,000 | - | - | - | - |
EBITDA Margin | -0.5% | -0.30 | -0.30 | -0.37 | -0.43 | -0.42 | -0.42 | -0.44 | -0.42 | -0.43 | -0.45 | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | 0% | 1,000 | 1,000 | 1,000 | 3,000 | 4,000 | 6,000 | 7,000 | 7,000 | 10,000 | 11,000 | 13,000 | 15,000 | 22,000 | 30,000 | 43,000 | 26,000 | 32,000 | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | 37,000 | 7,000 | 14,000 | 21,000 | 1,000 | - | 10,000 | 11,000 | -100,000 | 4,000 | - | 3,000 | -1,795,000 | 2,000 |
EBT Margin | 0% | -0.32 | -0.32 | -0.39 | -0.45 | -0.45 | -0.44 | -0.47 | -0.44 | -0.46 | -0.48 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 74.2% | -169,000 | -654,000 | -306,000 | -848,000 | -3,154,000 | -1,137,000 | -1,967,000 | -922,500 | -1,222,000 | -1,126,000 | -537,000 | -759,000 | -1,012,000 | -1,657,000 | -1,098,000 | -725,000 | -566,000 | -682,000 | - | - | - |
Net Income Margin | 8.7% | -0.10 | -0.11 | -0.47 | -0.71 | -0.71 | -0.51 | -0.54 | -0.37 | -0.37 | -0.36 | -0.45 | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -124.0% | -672,000 | -300,000 | 276,000 | -195,000 | -170,000 | -1,175,000 | -1,831,000 | -335,000 | -923,000 | -117,000 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -3.8% | 11,416 | 11,861 | 10,919 | 10,386 | 10,927 | 10,999 | 11,335 | 14,953 | 15,528 | 17,650 | 17,820 | 17,991 | 17,936 | 18,510 | 15,242 | 16,649 | 18,294 | 11,629 | 11,554 | 12,014 | 10,138 |
Current Assets | -3.3% | 8,130 | 8,405 | 8,506 | 7,914 | 8,324 | 8,261 | 9,118 | 11,122 | 11,657 | 13,634 | 13,621 | 14,840 | 14,667 | 15,154 | 11,755 | 13,070 | 14,809 | 8,299 | 8,117 | 8,437 | 7,172 |
Cash Equivalents | -15.6% | 3,633 | 4,307 | 4,622 | 4,060 | 3,836 | 3,634 | 3,940 | 4,179 | 5,421 | 6,973 | 7,350 | 8,278 | 8,163 | 8,249 | 5,155 | 7,046 | 8,962 | 4,166 | 3,855 | 4,318 | 3,608 |
Inventory | 12.5% | 2,779 | 2,470 | 2,268 | 2,126 | 2,348 | 3,153 | 3,488 | 4,664 | 4,679 | 4,462 | 4,649 | 5,087 | 4,679 | 5,304 | 5,385 | 4,769 | 3,649 | 2,562 | 2,128 | 2,314 | 2,040 |
Net PPE | -6.6% | 142 | 152 | 88.00 | 98.00 | 107 | 116 | 128 | 450 | 384 | 72.00 | 382 | 303 | 311 | 295 | 302 | 296 | 76.00 | 81.00 | 85.00 | 89.00 | 97.00 |
Goodwill | -5.1% | 759 | 800 | 800 | 759 | 800 | 800 | 800 | 800 | 759 | 759 | 800 | 800 | 759 | 800 | 759 | 759 | 759 | 759 | 759 | 759 | 759 |
Liabilities | -7.6% | 3,236 | 3,503 | 2,297 | 1,731 | 2,033 | 2,118 | 1,754 | 2,472 | 2,126 | 2,901 | 2,490 | 3,000 | 2,399 | 2,937 | 3,802 | 4,373 | 4,658 | 3,940 | 4,832 | 5,208 | 4,534 |
Current Liabilities | -8.7% | 1,929 | 2,113 | 1,828 | 1,197 | 1,415 | 1,412 | 1,551 | 2,111 | 1,748 | 2,390 | 1,823 | 2,170 | 1,408 | 1,325 | 2,379 | 2,765 | 3,108 | 2,428 | 3,116 | 3,292 | 3,110 |
Shareholder's Equity | -2.1% | 8,180 | 8,358 | 8,622 | 8,655 | 8,894 | 5,592 | 9,581 | 12,481 | 13,402 | 14,749 | 15,330 | 14,991 | 15,537 | 15,573 | 11,440 | 12,276 | 13,636 | 7,689 | 6,722 | 6,806 | 5,604 |
Retained Earnings | -0.1% | -144,600 | -144,406 | -143,752 | -143,570 | -143,100 | -142,831 | -141,983 | -138,829 | -137,700 | -135,725 | -134,700 | -133,521 | -132,395 | -131,858 | -131,100 | -130,087 | -128,430 | -127,332 | -127,188 | -126,444 | -125,502 |
Additional Paid-In Capital | 0.0% | 152,745 | 152,754 | 152,364 | 152,215 | 152,021 | 148,413 | 148,275 | 148,040 | 147,781 | 147,346 | 146,883 | 145,378 | 144,801 | 144,296 | 139,410 | 139,243 | 138,953 | 131,934 | 130,830 | 130,169 | 127,974 |
Shares Outstanding | 0.0% | 10,544 | 10,544 | 10,485 | 10,485 | 10,485 | 10,297 | 10,304 | 10,265 | 10,214 | 10,258 | 9,958 | 9,913 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | 3,289 | 3,279 | 3,260 | 3,242 | 3,054 | 3,054 | 3,054 | 3,053 | 3,051 | 3,052 | 3,046 | 3,040 | 3,014 | 3,009 | 3,003 | 3,000 |
Float | - | - | - | - | 10,421 | - | - | - | 9,879 | - | - | - | 60,900 | - | - | - | 43,900 | - | - | - | 17,800 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -124.0% | -672 | -300 | 598 | 226 | 276 | -195 | -170 | -1,072 | -1,797 | -335 | -910 | -117 | -55.00 | -1,526 | -1,817 | -1,720 | -1,840 | 364 | -614 | -1,329 | -697 |
Share Based Compensation | -102.3% | -9.00 | 390 | 149 | 194 | 319 | 179 | 254 | 277 | 272 | 434 | 268 | 281 | 276 | 206 | 172 | 179 | 222 | 670 | 354 | 150 | 158 |
Cashflow From Investing | - | - | - | - | - | - | - | - | -103 | -34.00 | - | -62.00 | - | -23.00 | - | -13.00 | - | - | - | -14.00 | - | -137 |
Cashflow From Financing | 33.3% | -2.00 | -3.00 | - | -2.00 | -74.00 | -111 | -69.00 | -67.00 | 281 | -37.00 | 46.00 | 231 | -3.00 | 4,615 | -65.00 | 28.00 | 6,638 | -55.00 | 171 | 2,038 | -137 |
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Net revenue: | ||
Total net revenues | $ 3,522 | $ 3,697 |
Cost of goods sold | 1,335 | 1,586 |
Gross margin | 2,187 | 2,111 |
Operating expenses: | ||
Selling, general and administrative | 2,142 | 2,124 |
Research and development | 212 | 239 |
Depreciation and amortization | 33 | 54 |
Total operating expenses | 2,387 | 2,417 |
Operating loss | (200) | (306) |
Other (expense) income: | ||
Interest expense | (1) | (1) |
Interest income | 25 | 12 |
Other (expense) income, net | 7 | (11) |
Total other income: | 31 | |
Net loss | $ (169) | $ (306) |
Net loss per common share, basic | $ (0.02) | $ (0.03) |
Net loss per common share, diluted | $ (0.02) | $ (0.03) |
Weighted average common shares outstanding, basic | 10,501,771 | 10,297,429 |
Weighted average common shares outstanding, diluted | 10,501,771 | 10,297,429 |
Comprehensive loss | $ (169) | $ (306) |
Product [Member] | ||
Net revenue: | ||
Total net revenues | 3,506 | 3,662 |
Royalty and Other Revenues [Member] | ||
Net revenue: | ||
Total net revenues | $ 16 | $ 35 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 3,633 | $ 4,307 |
Accounts receivable, net | 1,518 | 1,496 |
Inventory | 2,779 | 2,470 |
Prepaid expenses and other current assets | 200 | 132 |
Total current assets | 8,130 | 8,405 |
Property and equipment, net | 142 | 152 |
Lease right-of-use assets | 1,680 | 1,807 |
Intangible assets, net | 373 | 381 |
Goodwill | 759 | 759 |
License and supply agreement, net | 257 | 271 |
Other assets | 75 | 86 |
TOTAL ASSETS | 11,416 | 11,861 |
Current liabilities: | ||
Accounts payable | 1,114 | 873 |
Accrued expenses | 413 | 794 |
Current portion of lease liabilities | 402 | 446 |
Total current liabilities | 1,929 | 2,113 |
Lease liabilities, net of current portion | 1,307 | 1,390 |
TOTAL LIABILITIES | 3,236 | 3,503 |
COMMITMENTS AND CONTINGENCIES (Note 13) | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock, $.001 par value; 5,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | ||
Common stock, $.001 par value; 40,000,000 shares authorized at March 31, 2024 and December 31, 2023; 10,544,139 and 10,543,675 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 10 | 10 |
Additional paid-in capital | 152,745 | 152,754 |
Accumulated deficit | (144,575) | (144,406) |
TOTAL STOCKHOLDERS’ EQUITY | 8,180 | 8,358 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 11,416 | $ 11,861 |